Poster Session T - Cardiovascular Medicine and Research 3.
Dr. Masszi, Richárd
e6skpl
Semmelweis University Heart and Vascular Center
06304997593
masszi.richard@gmail.com
Evaluating the Predictive Value of Late Gadolinium Enhancement assessed by Cardiac Magnetic Resonance on Sudden Cardiac Death in Patients selected for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Implantation: a Systematic review and Meta-analysis
Masszi Richárd1, Zsigmond Előd János2, Ehrenberger Réka1, Turan Caner3, Fehérvári Péter3, Teutsch Brigitta3, Molnár Zsolt3, Drobni Zsófia4, Hajnalka Vágó4, Hegyi Péter3, Merkely Béla4, Kosztin Annamária4
1: Semmelweis University Heart and Vascular Center, Centre for Translational Medicine
2: Department of Cardiology, Military Hospital
3: Semmelweis University Centre for Translational Medicine
4: Semmelweis University Heart and Vascular Center
Poszter
Poster Session T - Cardiovascular Medicine and Research 3.
English
Cardiovascular Medicine and Research
Introduction: Late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance (CMR) can evaluate myocardial scar associated with a higher risk of sudden cardiac death (SCD), which can guide the selection between cardiac resynchronization therapy with or without a defibrillator (CRT-P/CRT-D).
Aims: Our aim was to investigate the association between LGE and SCD risk in patients with CRT using the LGE-CMR technique.
Methods: We performed a systematic literature search using four databases. The target population was CRT candidates. The primary endpoint was SCD. The risk of bias was assessed using the QUIPS tool.
Results: Fifteen eligible articles were included with a total of 2494 patients, of whom 27%, 56%, and 19% had an implantable cardioverter defibrillator (ICD), CRT-D, and CRT-P, respectively. Altogether, 54.71% of the cohort was LGE positive, who had a 72% higher risk for SCD (HR 1.72; 95% CI 1.18-2.50) compared to LGE negatives. In non-ischemic patients, the proportion of LGE positivity was 46.6%, with a significantly higher risk for SCD as compared to LGE negatives (HR 2.42; 95% CI 1.99-2.94). The subgroup of CRT-only patients showed no difference between the LGE-positive vs. negative candidates (HR 1.17; 95% CI 0.82-1.68). Comparable SCD risk was observed between articles with short- (OR 7.47; 95% CI 0.54-103.12) vs. long-term (OR 6.15; 95% CI 0.96-39.45) follow-up time.
Conclusion: LGE-CMR positivity was associated with an increased SCD risk; however, in CRT candidates, the difference in risk reduction between LGE positive vs. negative patients was statistically not significant, suggesting a role of reverse remodeling. LGE-CMR before device implantation could be crucial in identifying high-risk patients even in non-ischemic etiology.
Semmelweis University
Kosztin Annamária
I do not give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
poszter
nem rendelkezett róla
6887
16:45
16:48